Net profit of Windlas Biotech rose 31.01% to Rs 17.66 crore in the quarter ended June 2025 as against Rs 13.48 crore during the previous quarter ended June 2024. Sales rose 19.95% to Rs 210.09 crore in the quarter ended June 2025 as against Rs 175.15 crore during the previous quarter ended June 2024.
Particulars | Quarter Ended |
| Jun. 2025 | Jun. 2024 | % Var. |
Sales | 210.09 | 175.15 | 20 |
OPM % | 12.62 | 11.92 | - |
PBDT | 30.71 | 24.52 | 25 |
PBT | 23.26 | 18.31 | 27 |
NP | 17.66 | 13.48 | 31 |